332947-26-9(N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide)
Product Description
332947-26-9
CAS No.
332947-26-9
Chemical Name:
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide
CBNumber:
CB82034351
Molecular Formula:
C26H24ClN3O2S2
Formula Weight:
510.07
MOL File:
Mol file
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide Synonyms:
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide
Acetamide, N-(3-chloro-2-methylphenyl)-2-[[3,4,5,6,7,8-hexahydro-3-(4-methylphenyl)-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl]thio]-
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide
Property
Density
1.41±0.1 g/cm3(Predicted)
pka
12.52±0.70(Predicted)
Safety
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide
Suppliers
Global( 4)Suppliers
Finland 2
Russia 1
The Netherlands 1
Global 4
Supplier
Tel
Email
Country
ProdList
Advantage
Interbioscreen Ltd.
+7 (49) 6524-0091
screen@ibscreen.chg.ru
Finland
6178
60
VITAS-M LABORATORY, LTD.
+7 495 939 48 31
Russia
6754
64
PHARMEKS Ltd.
+7 (495) 702-9648
sales@pharmeks.com
Finland
6350
50
Specs
+31 15 251 8111
info@specs.net
The Netherlands
6835
70
332947-26-9(N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide)
Related Search:
N-(3-chloro-2-methylphenyl)-2-{[3-(4-methylphenyl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl}acetamide
Acetamide, N-(3-chloro-2-methylphenyl)-2-[[3,4,5,6,7,8-hexahydro-3-(4-methylphenyl)-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl]thio]-
332947-26-9
Copyright 2017 © ChemicalBook. All rights reserved